Intellia Therapeutics (NTLA) Misses Q2 EPS by 8c, beats revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. USO
7. NVDA
8. TLT
9. AMZN
10. META

Go back to Intellia Therapeutics (NTLA) Misses Q2 EPS by 8c, beats revenue
(NASDAQ: NTLA) Delayed: 12.49 +1.00 (8.70%)
Previous Close $11.49    52 Week High $30.40 
Open $11.99    52 Week Low $11.86 
Day High $12.87    P/E N/A 
Day Low $11.95    EPS $0.00 
Volume 3,970,727